LOCAL-CONTROL OF OPERABLE BREAST-CANCER AFTER RADIOTHERAPY ALONE

被引:45
作者
VANLIMBERGEN, E [1 ]
VANDERSCHUEREN, E [1 ]
VANDENBOGAERT, W [1 ]
VANWING, J [1 ]
机构
[1] UNIV HOSP LEUVEN, DEPT PATHOL, LOUVAIN, BELGIUM
关键词
D O I
10.1016/0277-5379(90)90115-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
221 patients with operable breast carcinoma stage Tis, T1, T2, T3, N0N1 were treated with radiotherapy alone without tumorectomy. The mean follow-up time was 15.5 years (range 5-22). The annual risk for local recurrence was 3% during the first 5 years and 1% during the following 10 years, resulting in an actuarial local control rate of 75.4% after 15 years. The risk for local recurrence was assessed in multivariate analysis and was significantly related to the size of the tumour measured on mammography (P = 0.0002), the radiation dose administered (P = 0.0018), the length of the split-course intervals being longer than 75 days (P = 0.001) and age (P = 0.019). Dose was related to response over a wide range as a function of tumour volume. All 18 patients with minimal tumour load (T0 and Paget's disease) treated with doses above 55 Gy in 6 weeks achieved local control. 5-year local control rates ranged from 40 to 100% for T1 carcinomas treated with 45-110 Gy, and from 0 to 95.3% for T2 carcinomas at the same dose. For T3 carcinomas local control varied between 50 and 83% at 60-110 Gy. The risk for local failure increased by 8% per cm tumour diameter. With exclusive radiotherapy, the doses needed to provide local control rates similar to those obtained after tumorectomy and irradiation are 10 Gy higher for T1 (95% 5 year control) and 35 Gy higher for T2 (90% 5 year control). © 1990.
引用
收藏
页码:674 / 679
页数:6
相关论文
共 41 条
  • [1] AMALRIC R, 1982, CANCER-AM CANCER SOC, V49, P30, DOI 10.1002/1097-0142(19820101)49:1<30::AID-CNCR2820490107>3.0.CO
  • [2] 2-L
  • [3] RADIOTHERAPY ALONE IN BREAST-CANCER .1. ANALYSIS OF TUMOR PARAMETERS, TUMOR DOSE AND LOCAL-CONTROL - THE EXPERIENCE OF THE GUSTAVE-ROUSSY INSTITUTE AND THE PRINCESS MARGARET HOSPITAL
    ARRIAGADA, R
    MOURIESSE, H
    SARRAZIN, D
    CLARK, RM
    DEBOER, G
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (10): : 1751 - 1757
  • [4] BACLESSE F, 1949, J RADIOL ELECTROL, V30, P323
  • [5] BATAINI JP, 1978, CANCER, V42, P2059, DOI 10.1002/1097-0142(197810)42:4<2059::AID-CNCR2820420457>3.0.CO
  • [6] 2-Q
  • [7] BEADLE GF, 1984, CANCER, V54, P2911, DOI 10.1002/1097-0142(19841215)54:12<2911::AID-CNCR2820541216>3.0.CO
  • [8] 2-V
  • [9] CALLE R, 1978, CANCER-AM CANCER SOC, V42, P2045, DOI 10.1002/1097-0142(197810)42:4<2045::AID-CNCR2820420455>3.0.CO
  • [10] 2-8